MoneyWorks4Me

Biocon board to approve un-audited financial results

08 Jul 2016 Evaluate

Biocon has informed that a meeting of the Board of Directors of the Company will be held on July 21, 2016, to approve the un-audited financial results for the quarter ended on June 30, 2016 (Q1). The Company will organize a conference call for analysts and investors on July 22, 2016. The details of the call will be available on the Company’s website closer to the scheduled event.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1791.95
Dr. Reddys Labs. 1200.55
Cipla 1323.45
Lupin 2001.10
Zydus Lifesciences 1135.00
View more..